A vial of Glutathione contains 1500mg. A vial of Glow contains 70mg in total across three components. The first is more than twenty times the second by mass, and that fact tells you nothing whatever about which is more active — but it does tell you something useful about both.
Proxiva Literature ReviewWhat the published research does and does not support
Key takeaways
- Mass is not comparable between compounds. Milligram quantities reflect the amount required for a molecule to do its work, not how powerful that molecule is.
- Glutathione is dosed in hundreds to thousands of milligrams because it functions stoichiometrically — consumed in the reactions it participates in, in roughly one-to-one proportion.
- Peptides acting through receptors or signalling are dosed in single or double digits because a signal is not consumed by being sent. The same molecule can act repeatedly.
- That distinction — consumed against catalytic or informational — predicts the dose range of almost any compound in this category before you look it up.
- The two serve unrelated research domains. No study has compared them and there is no endpoint on which both have been measured.
The mass gap and what it actually measures
Set the two vials side by side and the difference is hard to ignore. One holds 1500mg of a single substance. The other holds 70mg divided across three. The instinctive reading is that one is a much larger quantity of something and therefore, in some sense, stronger.
That reading is wrong, and correcting it is the most useful thing this comparison can offer, because the same error is made across the whole category.
Dose magnitude is set by mechanism. It answers the question of how much material is needed for the molecule to accomplish what it accomplishes, and that requirement varies across orders of magnitude between mechanisms that are equally consequential. A compound requiring grams is not thereby weaker than one requiring micrograms. It is doing a different kind of work.
Once that is clear, the 21-fold gap stops being a puzzle and becomes a piece of evidence about what each compound is.
Consumed, or not consumed
The distinction that governs dose range is whether the molecule is used up by doing its job.
Molecules that are consumed
Glutathione participates in redox chemistry. Its function depends on a thiol group that is oxidised in the course of the reaction it takes part in. Each molecule handles roughly one event and is changed by doing so. Regeneration systems exist, but the stoichiometry is essentially one-to-one at the point of action.
A molecule working this way needs to be present in quantity proportional to the amount of work required. There is no way around this: the arithmetic of one-for-one is unforgiving, and it places compounds of this type in the hundreds-to-thousands of milligrams range as a matter of chemistry rather than convention. Related compounds such as L-carnitine, which functions in substrate transport, sit in comparable ranges for comparable reasons.
Molecules that are not
The components of Glow work differently. GHK-Cu, TB-500 and BPC-157 act through signalling — binding, initiating a response, and remaining available to do so again. A signal is not consumed by being sent.
This decouples quantity from effect in a way stoichiometric chemistry does not permit. One molecule can initiate many events, so the amount required is set by how much is needed to reliably produce a signal rather than by the volume of work to be done. Single and double-digit milligram quantities follow, and that is why every peptide in this catalogue sits in that range while the redox compounds do not.
A rule that works before you look anything up
The distinction above generalises into something practically useful, which is unusual for a mechanistic point.
Given an unfamiliar compound and its dose range, the range constrains what the mechanism can be. Gram quantities indicate something consumed in proportion to the work done — a substrate, a reductant, a transported species. Single-digit milligram quantities or below indicate something signalling, catalytic or informational, where one molecule acts repeatedly.
Run in reverse it is equally useful. Encountering a claim that a signalling peptide requires gram quantities, or that a stoichiometric antioxidant is active in micrograms, should prompt scepticism before any other checking. Such a claim asserts a mismatch between mechanism and quantity that would need substantial explanation, and sources making it rarely supply one.
The rule also explains why cross-compound comparisons by mass are meaningless. Comparing 1500mg of one thing to 70mg of another compares two numbers that were set by different physical constraints. It is arithmetic performed on incompatible units, and it is done constantly in this field.
The same test applied across the catalogue sorts it immediately: NAD+ in the hundreds of milligrams, Glutathione in the thousands, and every peptide from KPV through Epithalon to Selank in single or double digits. The pattern is not a coincidence of pricing or packaging.
Different domains, not competing options
Beyond dose, these two belong to research areas that do not overlap.
Glutathione concerns redox balance — the handling of oxidative species, the maintenance of cellular reducing capacity, and the chemistry downstream of both. This is old, settled biochemistry with a literature measured in decades and a mechanism that is not in dispute.
The Glow components concern tissue signalling: matrix interactions, cytoskeletal organisation, and processes associated with repair. These have their own literatures of varying weight, with GHK-Cu considerably the best characterised of the three.
No endpoint has been used to measure both. There is consequently no comparison to report, and any source ranking them has constructed the ranking rather than found it. The useful question is which domain the work belongs to, and that question resolves the choice completely.
Verification differs in kind, not just difficulty
Both should arrive with a batch-matched certificate, and in both cases identity by mass spectrometry should be read before purity by chromatography.
For a single well-characterised compound, that is close to the whole procedure. Identity and specification are the same claim, and a certificate confirming the right molecule at the stated purity has verified what needed verifying.
For a blend it is not. A certificate can confirm that three components are present and pure while reporting nothing about their proportions, and for a blend the proportions are the product. Confirm that quantity per component is reported and that the figures reconcile with the stated total. This check is skipped more often than any other and it is the one that distinguishes a verified blend from a verified ingredient list.
The blend also carries the failure mode of length and complexity across three separate syntheses rather than one, which multiplies the opportunities for a batch to be subtly wrong rather than obviously so.
Handling
Both are supplied lyophilised and are stable in that state under refrigeration. Both shorten substantially once reconstituted with bacteriostatic water, after which cold storage stops being optional.
The specific vulnerability differs. Glutathione's function depends on a thiol group, and thiols oxidise on exposure to air. The molecule is therefore sensitive to precisely the thing that its own mechanism concerns, which makes minimising headspace exposure and avoiding unnecessary vial entries more consequential here than for most compounds.
The blend's sensitivity centres on its copper-containing component, which is what makes the reconstituted solution blue and which rewards avoiding vigorous agitation and unnecessary light. Both call for the same underlying discipline — gentle addition against the vial wall, dissolution without forcing, minimal temperature cycling — but they are protecting against different chemistry.
What is not known
For glutathione, the mechanism is settled and the open questions concern delivery and disposition rather than function. That is an unusually comfortable position for anything in this catalogue.
For the blend, the components have separate literatures and the combination has none. No study examined these three together at these ratios, so statements about the blend as a blend are extrapolation from its parts — reasonable extrapolation in some cases, but extrapolation, and worth identifying as such when reading confident claims.
For the pair, nothing has been established because nothing has been asked. They have never been measured against each other and there is no reason anyone would have done so.
Frequently asked questions
Why does one vial contain 1500mg and the other 70mg?
Mechanism sets dose. Glutathione is consumed roughly one-for-one in the redox reactions it participates in, so quantity must scale with the work. The Glow components act through signalling, where one molecule can act repeatedly, so far less material is required.
Does the larger vial mean a stronger product?
No. Mass reflects how much material a mechanism requires, not how powerful it is. Comparing 1500mg of one compound to 70mg of another compares numbers set by different physical constraints.
Do they do similar things?
No. Glutathione concerns redox balance and cellular reducing capacity. The Glow components concern tissue signalling and repair-associated processes. The domains do not overlap.
Which has better evidence?
Glutathione, by a wide margin — its mechanism has been settled biochemistry for decades. Among the blend's components, GHK-Cu is the best characterised, and the combination itself has no evidence as a combination.
Can I compare doses between them?
No. Dose ranges are set by whether a molecule is consumed in its reaction. Compounds on opposite sides of that divide have no common scale, so cross-compound dose comparison is arithmetic on incompatible units.
Is one harder to verify?
The blend, in kind rather than degree. A single compound's identity and specification are one claim; a blend's are two, and a certificate confirming components are present without quantifying them leaves the specification untested.
Related research compounds
- GLP1 S — $60
- DSIP – 15mg — $64.00
- GLP1 - S Pen 60mg/3ml — $250
- L-Carnitine Full Kit (10 Vials) — 20% Off — $220
- MOTS-C Pen 60mg/3ml — $250
- Selank + Semax Nasal Spray — $90
- Tesa-morelin — $90
- PT-141 – 10mg — $60
- NAD+ Full Kit (10 Vials) — 20% Off — $200
Further reading
Research use only. All products referenced on this page are sold strictly for laboratory and research purposes. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure, or prevent any disease. They are not for human or veterinary consumption. Handling should be performed only by qualified individuals in an appropriate laboratory setting.